Abstract
Discovery of cisplatin furthered the development of many platinum and non-platinum drugs for anticancer and cell imaging applications. However, non-selective nature of these drugs exert toxicity to both, cancer and normal cells. This review focuses on use of external stimuli viz. UV-light and enzyme nitroreductase to release the drugs specifically in cancer cells to exert anticancer activity as well as release a fluorophore for imaging hypoxic cells.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
